ArticleRheumatology (Oxford, England)2025
When to address fatigue in juvenile idiopathic arthritis during clinical visits based on the JAMAR.
Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesFatigue is a prevalent but overlooked issue among patients with Juvenile Idiopathic Arthritis (JIA) in clinical practice. The internationally widely used Juvenile Arthritis Multidimensional Assessment Report (JAMAR) does not include items on fatigue. We evaluated whether items from its Quality of Life (QoL) section could be used as proxy measurement for fatigue, prompting practitioners to address issues with fatigue during a clinical visit.
methods105 JIA patients at the Wilhelmina Children's Hospital (WCH) completed the JAMAR and Checklist Individual Strength-8 (CIS-8), a questionnaire with validated cut-off score for severe fatigue in rheumatic conditions. Correlations were inspected to test whether QoL items 3 (difficulty with energy-demanding activities) and 9 (concentration or attention issues) correlated strongest with severe fatigue. With binary logistic regressions and ROC analyses, the proxy's predictive value and cut-off were determined. The proxy was re-used in the EPOCA cohort for comparison.
resultsThe proposed items showed the strongest correlation with severe fatigue (ritem3 = 0.644 and ritem9 = 0.565). Their sum score represented the proxy (range 0-6). The proxy was a significant predictor of severe fatigue controlled for age, sex, and disease activity (P < 0.001). Area Under the Curve was 0.911, sensitivity 90% and specificity 69.6% with cut-off score ≥1. According to the proxy, fatigue should be addressed in 58.1% of WCH patients and in 56.6% of the EPOCA cohort.
conclusionThe proxy can be used to estimate whether issues with fatigue should be explored during clinical visits. To quantify fatigue severity levels, we recommend using the CIS-8 or another fatigue questionnaire.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.